期刊文献+

胰岛素泵治疗2型糖尿病的药物经济学评价 被引量:7

Analysis on Pharmaceutical Economics of Continuous Subcutaneous Insulin Injection for Treating Type-2 Diabetes Mellitus
原文传递
导出
摘要 目的比较胰岛素泵和传统皮下强化注射胰岛素治疗2型糖尿病的成本效果。方法将115例2型糖尿病住院患者分成2组,一组住院过程中使用胰岛素泵治疗(A组)58例,另一组强化皮下注射胰岛素(B组)57例,1周后观察2组的降糖效果。采用成本-效果分析法对2组患者进行分析,效果指标选择血糖降低有效率。结果 A组的成本为616.6元,有效率为96.6%;B组的成本为512.2元,有效率为91.2%,A组的成本效果比(C/E)为6.38,B组的C/E为5.62。A组与B组相比,每增加一单位有效率,需要增加成本1 933.33元。结论强化皮下注射胰岛素治疗2型糖尿病具有较好的绝对经济效率,但与胰岛素泵治疗相比,后者具有较好的增量成本效果比。 OBJECTIVE To compare the economical effectiveness of continuous subcutaneous insulin injection(group A) and multiple daily injection(group B) for treating type-2 diabetes mellitus.METHODS Using cost-effectiveness analysis(CEA) on pharmaceutical economics to compare the cost effectiveness of the group A and group B.RESULTS The cost for group A and B were 616.6 and 512.2 Yuan,respectively.The total effective rates of controlling blood glucose were 96.6% and 91.2%,respectively.The cost-effectiveness ratios were 6.38 and 5.62,respectively.To increase one unit effective rate in group A need to raise the cost of 1 933.33 Yuan.CONCLUSION Group B has higher absolute economic efficiency for the treatment of type-2 diabetes.But group A has higher incremental cost effectiveness ratio than group B.
出处 《中国现代应用药学》 CAS CSCD 2012年第4期367-370,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 胰岛素泵 2型糖尿病 成本-效果分析 continuous subcutaneous insulin injection type-2 diabetes mellitus cost-effectiveness analysis
  • 相关文献

参考文献3

二级参考文献37

  • 1李立明.面向21世纪课程教材-流行病学[M].北京:人民卫生出版社,2001.254-267. 被引量:1
  • 2.中国城市统计年鉴2000[M].中国统计出版社,.. 被引量:1
  • 3赵文海.糖尿病流行病学调查报告.中国药物经济学报告,2002,7(4):36-38. 被引量:2
  • 4NEUMILLER J J, CAMPBELL R K. Liraglutide: a once-daily incretin mimetic for the treatment of type 2 diabetes mellitus [J]. Ann Pharmacother, 2009, 43 (9): 1433-1444. 被引量:1
  • 5WAUGH N, CUMMINS E, ROYLE P, et al. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation [J]. Health Technol Assess, 2010, 14 (36): 241-248. 被引量:1
  • 6BUSE J B, KLONOFF D C, NIELSEN L L, et al. Metabolic effects of two years of exenatide treatment on diabetes, obesity and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials [J]. Clin Ther, 2007, 29(1): 139-153. 被引量:1
  • 7BUSE J B, HENRY R R, HAN J, et al. Effects of Exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes [J]. Diabetes Care, 2004, 27(11): 2628-2635. 被引量:1
  • 8DEFRONZO R A, RATNER R E, HAN J, et al. Effects of Exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes [J]. Diabetes Care, 2005, 28(5): 1092-1100. 被引量:1
  • 9Z1NMAN B, HOOGWERF B J, DURAN G S, et al. The effect of adding Exenatide to a tbiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial [J]. Ann Intern Med, 2007, 146(7): 477-485. 被引量:1
  • 10NAUCK M A, DURAN S, KIM D, et al. A comparison of twice-daily Exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study [J]. Diabetologia, 2007, 50(2): 259-267. 被引量:1

共引文献116

同被引文献78

引证文献7

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部